NYSE US 100

NYSE US 100 handeln
18.249,86 PKT -170,50 PKT -0,93 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE US 100-Werten

Datum Rating Analyst
22.06.12 McDonalds overweight Piper Jaffray & Co.
22.06.12 IBM neutral Goldman Sachs Group Inc.
22.06.12 Procter Gamble outperform Sanford C. Bernstein and Co., Inc.
22.06.12 Citigroup outperform Credit Suisse Group
22.06.12 FedEx buy Stifel, Nicolaus & Co., Inc.
21.06.12 Bayer outperform Credit Suisse Group
21.06.12 Carnival buy UBS AG
21.06.12 Procter Gamble neutral Sarasin Research
21.06.12 Bayer outperform Sanford C. Bernstein and Co., Inc.
21.06.12 IBM neutral UBS AG
21.06.12 Caterpillar neutral UBS AG
21.06.12 Procter Gamble halten Independent Research GmbH
21.06.12 Eli Lilly neutral Credit Suisse Group
21.06.12 Schlumberger buy Sarasin Research
21.06.12 Altria buy Deutsche Bank Securities
21.06.12 FedEx sector perform RBC Capital Markets
21.06.12 FedEx overweight Barclays Capital
21.06.12 FedEx hold Jefferies & Company Inc.
21.06.12 ConocoPhillips sell Goldman Sachs Group Inc.
21.06.12 Raytheon Technologies outperform William Blair
21.06.12 Procter Gamble neutral J.J.B. Hilliard, W.L. Lyons, Inc.
20.06.12 Bayer buy Citigroup Corp.
19.06.12 Valero Energy buy UBS AG
19.06.12 Carnival buy UBS AG
19.06.12 Johnson Johnson buy UBS AG
19.06.12 Bank of America halten Independent Research GmbH
19.06.12 Walt Disney outperform RBC Capital Markets
19.06.12 Pfizer overweight JP Morgan Chase & Co.
18.06.12 Carnival outperform Exane-BNP Paribas SA
18.06.12 FedEx neutral Nomura
18.06.12 FedEx overweight Barclays Capital
15.06.12 Caterpillar outperform Macquarie Research
15.06.12 Transocean outperform RBC Capital Markets
15.06.12 Transocean buy UBS AG
15.06.12 McDonalds neutral Goldman Sachs Group Inc.
14.06.12 Verizon neutral UBS AG
14.06.12 Bayer neutral J.P. Morgan Cazenove
14.06.12 Verizon neutral Nomura
14.06.12 Illinois Tool Works outperform Barrington Research
14.06.12 CME Group A neutral J.P. Morgan Cazenove